We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.35%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$216M
AUM Growth
+$17.6M
(+8.9%)
Cap. Flow
-$4.87M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
44.96%
Holding
70
New
3
Increased
13
Reduced
28
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MODN
MODEL N, INC.
MODN
|
+$4.66M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$4.64M |
| 3 |
Option Care Health
OPCH
|
+$4.57M |
| 4 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$3.98M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$8.53M |
| 2 |
AngioDynamics
ANGO
|
+$3.36M |
| 3 |
ELGX
Endologix Inc
ELGX
|
+$3.12M |
| 4 |
Arrowhead Research
ARWR
|
+$2.37M |
| 5 |
Insmed
INSM
|
+$2.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 74.24% |
| 2 | Energy | 4.55% |
| 3 | Communication Services | 2.46% |
| 4 | Real Estate | 1.52% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOC
26
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.27M | 1.52% |
155,849
-2,373
| -1% | -$45.5K |
|
|
ELGX
27
DELISTED
Endologix Inc
ELGX
| $3.22M | 1.49% |
25,843
-27,170
| -51% | -$3.12M |
|
|
CYNA
28
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $3.16M | 1.46% |
188,577
-3,403
| -2% | -$45.8K |
|
|
BLUE
29
DELISTED
bluebird bio
BLUE
| $2.9M | 1.34% |
5,176
-82
| -2% | -$46.4K |
|
30
Veracyte
VCYT
$3.7B
| $2.75M | 1.27% |
546,021
-10,444
| -2% | -$56K |
|
31
Bio-Techne
TECH
$11.2B
| $2.72M | 1.26% |
96,584
-1,440
| -1% | -$37K |
|
32
Alkermes
ALKS
$8.22B
| $2.68M | 1.24% |
62,068
-1,160
| -2% | -$47.9K |
|
|
TEAR
33
DELISTED
TearLab Corporation
TEAR
| $2.41M | 1.12% |
376,043
+1,427
| +0.4% | +$10.4K |
|
|
IMMU
34
DELISTED
Immunomedics Inc
IMMU
| $2.29M | 1.06% |
987,854
-555,688
| -36% | -$1.86M |
|
|
STRM
35
DELISTED
Streamline Health Solutions
STRM
| $2.15M | 1% |
119,469
+2,376
| +2% | +$46.1K |
|
36
Vertex Pharmaceuticals
VRTX
$121B
| $2.05M | 0.95% |
23,835
-441
| -2% | -$38.1K |
|
|
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
| $1.98M | 0.92% |
554,841
+28,571
| +5% | +$93.1K |
|
|
CPHD
38
DELISTED
Cepheid Inc
CPHD
| $1.91M | 0.89% |
62,178
-1,160
| -2% | -$35.1K |
|
39
QuidelOrtho
QDEL
$1.14B
| $1.5M | 0.69% |
83,698
-64,639
| -44% | -$1.12M |
|
|
NSTG
40
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.49M | 0.69% |
+118,547
| New | +$1.72M |
|
41
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.44M | 0.67% |
18,515
-340
| -2% | -$28.9K |
|
42
Humana
HUM
$43.7B
| $637K | 0.3% |
3,540
| – | – |
|
|
AET
43
DELISTED
Aetna Inc
AET
| $637K | 0.3% |
5,215
| – | – |
|
44
Bristol-Myers Squibb
BMY
$133B
| $610K | 0.28% |
8,290
| – | – |
|
45
Becton Dickinson
BDX
$45.6B
| $576K | 0.27% |
3,480
| – | – |
|
46
Elevance Health
ELV
$81.5B
| $538K | 0.25% |
4,095
| – | – |
|
47
Novartis
NVS
$297B
| $501K | 0.23% |
6,774
| – | – |
|
|
AGN
48
DELISTED
Allergan plc
AGN
| $470K | 0.22% |
2,035
| – | – |
|
49
Johnson & Johnson
JNJ
$618B
| $463K | 0.21% |
3,820
| – | – |
|
|
AGRX
50
DELISTED
Agile Therapeutics
AGRX
| $454K | 0.21% |
30
-1
| -3% | -$13.7K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, First Light Asset Management held 70 positions worth $216M, up 8.9% from $198M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
First Light Asset Management's Q2 2016 filing shows 3 new, 13 increased, 28 reduced and 5 closed positions. Its largest new stake was MODEL N, INC.: 397,152 shares worth $5.3M. The largest sale was NeoGenomics, an estimated $8.53M.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 80% a quarter earlier, followed by Energy and Communication Services.
- First Light Asset Management's largest Q2 2016 buy was MODEL N, INC.: 397,152 shares worth $5.3M.
- First Light Asset Management added most to Akorn Inc in Q2 2016, an estimated $4.64M increase.
- First Light Asset Management's biggest Q2 2016 reduction was NeoGenomics, cutting an estimated $8.53M.
- First Light Asset Management fully exited AngioDynamics in Q2 2016, selling an estimated $3.36M.
- First Light Asset Management's ten largest holdings make up 45% of its $216M portfolio in Q2 2016.
- First Light Asset Management opened 3 new positions and closed 5 in Q2 2016.
- First Light Asset Management's portfolio value rose 8.9% quarter-over-quarter to $216M.
Based on First Light Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.